Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy
Clinical trial NCT07359963 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07359963
- Sponsor
- Regend Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-15
- Primary completion
- 2027-02-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.